The $36 million market cap company is raising funds via joint lead managers Bell Potter and Unified Capital Partners.

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

Control Bionics Ltd. ( (AU:CBL)) has shared an update. Control Bionics Limited has lodged a notice with the ASX for a proposed issue of up to 8,443,747 new fully paid ordinary shares. The securities ...

Control Bionics Ltd. ( (AU:CBL)) has shared an update. Control Bionics Limited has issued 8,443,747 fully paid ordinary shares on 31 December 2025 without a prospectus or product disclosure statement, ...

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).